Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus.
about
Current prospects and challenges for epilepsy gene therapySilencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon VectorsThe potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples.Rhythm and blues: animal models of epilepsy and depression comorbidity.Gene therapy in epilepsy-is it time for clinical trials?Blockade of excitatory synaptogenesis with proximal dendrites of dentate granule cells following rapamycin treatment in a mouse model of temporal lobe epilepsy.Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection?Changes in the sensitivity of GABAA current rundown to drug treatments in a model of temporal lobe epilepsyImplication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements.Finding a better drug for epilepsy: antiepileptogenesis targets.Antiepileptic and neuroprotective effects of human umbilical cord blood mononuclear cells in a pilocarpine-induced epilepsy model.Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review.Novel approaches to epilepsy treatment.Progress in gene therapy for neurological disorders.Design of innovative therapeutics for pharmacoresistant epilepsy: challenges and needs.A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.Anticonvulsive activity of (1S)-(-)-verbenone involving RNA expression of BDNF, COX-2, and c-fos.Increased Expression of Brain-Derived Neurotrophic Factor Transcripts I and VI, cAMP Response Element Binding, and Glucocorticoid Receptor in the Cortex of Patients with Temporal Lobe Epilepsy.Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.BDNF-TrkB signaling pathway is involved in pentylenetetrazole-evoked progression of epileptiform activity in hippocampal neurons in anesthetized rats.Suppression of epileptogenesis-associated changes in response to seizures in FGF22-deficient mice.Effect of eugenol on lithium-pilocarpine model of epilepsy: behavioral, histological, and molecular changes.Cutting through the complexity: the role of brain-derived neurotrophic factor in post-traumatic epilepsy (Commentary on Gill et al.).Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase.Physical exercise alters the activation of downstream proteins related to BDNF-TrkB signaling in male Wistar rats with epilepsy.Alpha-Linolenic Acid-Induced Increase in Neurogenesis is a Key Factor in the Improvement in the Passive Avoidance Task After Soman Exposure.Effect of 17ß-estradiol on zinc content of hippocampal mossy fibers in ovariectomized adult rats.Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy.
P2860
Q27002627-0B62CF2B-DEE9-48B7-9277-60D0DA843588Q27318403-5101FDA3-8567-4D40-BC22-A60C3F048461Q30576758-0EF32C2F-DC1D-4B6E-9D68-475BDEF52CB5Q30665824-C39748CD-188B-4E58-A83A-D61EEC32041BQ33974889-5A05DCCD-76E3-4999-8101-7DC985F1C81AQ34410588-3C5E40C6-A482-4F42-96D2-514105353832Q34614293-C67C30B4-34C6-4B6C-94F5-CD48160C9774Q36547098-4DA45492-E664-4176-8B40-3967F166367FQ37001922-EE3504B7-3742-4CC6-B884-2F0414710FCEQ37168681-C429BEA9-2807-40C5-905E-25996BD386F0Q37232240-ECDD5978-DAF1-4C02-9B75-8F7BB519995FQ37569445-DACBA1B6-9C0E-4624-A34D-DAA66064BCB5Q37982345-3A715D3F-0874-42D2-BB18-B18309F3F12FQ38056185-A2F13956-F95A-410F-BBF7-BDD6A931D579Q38100997-1FCD7D75-42D2-4B11-9313-5ACF389982AEQ38104382-49F2A66E-1C26-4637-8C57-D32EA0B07022Q38246632-DB467B6D-BA04-4D6A-B937-0CC6D4217904Q38747432-09A7BDDE-B23C-4DDF-81B2-DE31EAA0F2AAQ38773560-7F71968D-47D3-4CAE-B16C-0A21AA9C69A7Q38856602-5078174B-FFD2-48BD-A3ED-AB9BCBCA3EDDQ39441266-E96CFDEF-951A-472A-820D-7BA71F044BECQ39919211-6B920D49-0837-414B-80E7-C1E6404B582FQ41507790-FF406D88-9BCD-49A9-B12D-B3CAD3BEA32FQ41881797-6A270058-9953-4F8C-9C51-AB67F1B37FDFQ42513030-6816EBB1-4BF8-4531-88BD-4BB81DE00DEFQ47446247-8DFC62B7-645A-4441-9162-2EECA7BECB10Q47656370-CDD71812-F7A0-4A8D-980D-286B3E835280Q48425069-771C48FC-C773-43E0-B946-2B5C931807D5Q54918000-1E193F25-D695-4CE3-BB35-0FB093376811
P2860
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Localized overexpression of FG ...... ne-induced status epilepticus.
@en
Localized overexpression of FG ...... ne-induced status epilepticus.
@nl
type
label
Localized overexpression of FG ...... ne-induced status epilepticus.
@en
Localized overexpression of FG ...... ne-induced status epilepticus.
@nl
prefLabel
Localized overexpression of FG ...... ne-induced status epilepticus.
@en
Localized overexpression of FG ...... ne-induced status epilepticus.
@nl
P2093
P2860
P1433
P1476
Localized overexpression of FG ...... ine-induced status epilepticus
@en
P2093
Andrea Marzola
Beatrice Paradiso
Elena Berto
Graciela Navarro Mora
Paolo F Fabene
Roberta Bovolenta
Silvia Zucchini
P2860
P304
P356
10.1111/J.1528-1167.2010.02930.X
P577
2011-01-26T00:00:00Z